Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A simple qualitive procedure for the detection of chloroquine in urine for use in clinical analytical toxicology in resource poor settings.

The Central African journal of medicine·2017
Same author

Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program.

Bone marrow transplantation·2012
Same author

Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support.

International journal of breast cancer·2012
Same author

Optimal use of G-CSF administration after hematopoietic SCT.

Bone marrow transplantation·2009
Same author

Ovarian recovery after stem cell transplantation.

Bone marrow transplantation·2007
Same author

Cytotoxic activity of gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukemia correlates with the expression of protein kinase Syk.

Leukemia·2006
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles

Related Experiment Video

Updated: May 3, 2026

Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function
11:50

Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function

Published on: November 4, 2016

11.6K

Methods for Retrovirus-Mediated Gene Transfer to CD34(+) Enriched Cells.

A B Bahnson1, M Nimgaonkar, E D Ball

  • 1, .

Methods in Molecular Medicine
|February 5, 2014
PubMed
Summary
This summary is machine-generated.

Hematopoietic stem cells (HSCs) continuously replenish the immune system and self-renew. Enriched HSCs using CD34 markers are vital for transplantation and gene therapy applications.

More Related Videos

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.1K
Expression of Fluorescent Fusion Proteins in Murine Bone Marrow-derived Dendritic Cells and Macrophages
09:07

Expression of Fluorescent Fusion Proteins in Murine Bone Marrow-derived Dendritic Cells and Macrophages

Published on: October 30, 2018

10.1K

Related Experiment Videos

Last Updated: May 3, 2026

Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function
11:50

Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function

Published on: November 4, 2016

11.6K
Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
11:16

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

7.1K
Expression of Fluorescent Fusion Proteins in Murine Bone Marrow-derived Dendritic Cells and Macrophages
09:07

Expression of Fluorescent Fusion Proteins in Murine Bone Marrow-derived Dendritic Cells and Macrophages

Published on: October 30, 2018

10.1K

Area of Science:

  • Hematology
  • Immunology
  • Stem Cell Biology

Background:

  • Hematopoietic stem cells (HSCs) are crucial for maintaining the immune and hematopoietic systems through continuous replenishment and self-renewal.
  • HSCs can be isolated from hematopoietic tissues using monoclonal antibodies (MAbs) targeting the CD34 antigen, a well-established marker for hematopoietic progenitors.
  • Enriched HSC populations are of significant interest for therapeutic applications.

Purpose of the Study:

  • To highlight the importance of Hematopoietic stem cells (HSCs) in maintaining hematopoietic and immune systems.
  • To discuss the utility of CD34 as a marker for enriching HSCs.
  • To explore the potential of enriched HSC populations in transplantation and gene therapy.

Main Methods:

  • Utilizing monoclonal antibodies (MAbs) that bind to the CD34 antigen to enrich HSC populations from hematopoietic tissues.
  • Investigating the properties and applications of CD34-enriched HSCs.

Main Results:

  • CD34 is a universally recognized marker for identifying and isolating hematopoietic progenitors.
  • Enriched HSC populations demonstrate potential for rapid hematopoietic reconstitution in myeloablated patients.
  • Enriched HSCs serve as effective targets for gene transfer.

Conclusions:

  • Hematopoietic stem cells (HSCs) are essential for continuous replenishment and self-renewal of the hematopoietic and immune systems.
  • The CD34 antigen is a reliable marker for enriching HSCs, facilitating their isolation and study.
  • Enriched HSC populations hold significant promise for hematopoietic stem cell transplantation and gene therapy, offering rapid reconstitution and efficient gene transfer targets.